Skip to main content

Table 2 Comparison of the kappa values, sensitivities and specificities obtained between the HC2 (gold standard) and the PCR-based techniques

From: Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention

PCR technique Kappa value (CI 95%) Sensitivity (CI 95%) Specificity (CI 95%)
GP-EIA 0.71 (0.63–0.78) 70,4% (62,1 – 78,7) 96,2% (94,3 – 98,1)
BSGP-EIA 0.78 (0.71–0.84) 77,4% (69,7 – 85,1) 96,9% (95,3 – 98,5)
pU 0.63 (0.55–0.72) 60,9% (52,0 – 69,8) 96,5% (94,6 – 98,3)
BSGP-EIA + pU 0.82 (0.76–0.88) 88,7% (82,8 – 94,6) 95,1% (93,1 – 97,1)